EU Commission: How to prepare for a "Hard Brexit"
Recommendation

17/18 June 2026
Copenhagen, Denmark
Supervision of the Pharmaceutical Quality System: Challenges and Opportunities
If a Withdrawal Agreement between the European Union (EU) and the United Kingdom (United Kingdom, UK) is not concluded, which would create a transitional period until the end of 2020 (with the possibility of an extension provided for in the withdrawal agreement), the United Kingdom will be treated as a non-EU country (literally as a third country) from 30 March 2019 - this also applies in particular to customs provisions.
The European Commission is now fostering its support in preparing EU companies for such a no deal scenario ("Hard Brexit").
The EU Commission now reiterates that affected companies must take all steps necessary before 30 March 2019 (or before a postponed date) to avoid possible adverse effects. To support this, the European Commission has set up a "Brexit Checklist" and its website with a list of practical tips and recommendations.
Related GMP News
29.05.2026European QP Association Developments January through April 2026
15.04.2026ICH Q9 Training Package updated
01.04.2026New EMA GMP Guidelines in the next three Years
01.04.2026New EMA Guidance: Risk Management for Elemental Impurities in Veterinary Medicinal Products
18.03.2026Sampling in the Focus of the FDA
11.03.2026EU Pharma Package: Final Texts officially published


